If you have breast cancer, your doctor may prescribe Aromasin for you. It’s a prescription drug that’s used in females* who have gone through menopause. Aromasin is used to treat the following in ...

CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on ...

Postmenopausal women with hormone receptor-positive breast cancer who received Aromasin after five years of tamoxifen were 56% less likely to have a relapse of breast cancer. New data from the ...

Sept. 19, 2005 — The European Commission has approved exemestane tablets for the treatment of estrogen receptor–positive invasive early breast cancer after two to three years of initial adjuvant ...

"Aromasin provided patients with improved relapse-free survival despite early study closure, unblinding and crossover in the placebo arm," said Dr. Terry Mamounas, NSABP breast committee chairman and ...

Exemestane (Aromasin) is an aromatase inhibitor, prescribed for advanced breast cancer in postmenopausal women who are no longer responsive to anti-estrogen therapy.It works by decreasing the amount ...

The role of maintenance bevacizumab in patients with metastatic breast cancer treated with chemotherapy and bevacizumab upon achieving complete response or maximal radiologic response with stable ...

Aromasin (exemestane) provides alternative option for postmenopausal women in breast cancer prevention. The highest risk factor for breast cancer is age, especially after 60 and after menopause, which ...

The drug exemestane worked slightly better than the drug tamoxifen at preventing a recurrence of breast cancer in certain premenopausal women, according to a new study. Almost 93 percent of women on ...